AltheaDx Raises $6M

AltheaDx, Inc., a San Diego, CA-based molecular diagnostics company that develops companion diagnostics for biopharmaceutical partners, has completed a $6m Series A equity financing.
The round was led by San Francisco based Telegraph Hill Partners (THP).
This Series A funding will support the company’s existing biopharma partnerships that are focused on the development of biomarkers and companion diagnostics which will be instrumental in bringing safer therapeutics to patients.
AltheaDx currently has six development programs underway with biopharma partners. 

Join the discussion